KINGS DAUGHTERS MEDICAL CENTER — History
CCN 250057 | 3-year financial timeline | COVID resilience: 34/100
🛡️ Public data only — no PHI permitted on this instance.
$92M
Latest Revenue (FY2022)
+3.7%
Revenue CAGR (3yr)
-8.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $85M | $94M | $92M | -2.9% | +3.7% |
| Operating Expenses | $90M | $97M | $99M | +2.1% | +4.9% |
| Operating Margin | -5.9% | -3.2% | -8.4% | -166.0% | +0.0% |
| Net Income | $-5M | $-3M | $-8M | -158.4% | +0.0% |
| Licensed Beds | 90 | 90 | 22 | -75.6% | -50.6% |
| Total Patient Days | 7,720 | 8,936 | 6,820 | -23.7% | -6.0% |
| Medicare Day % | 47% | 38% | 39% | +1.8% | -8.9% |
| Medicaid Day % | 22% | 21% | 22% | +7.6% | +1.0% |
COVID Impact & Recovery
Resilience Score: 34/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +7.6% ($85M → $92M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.7%
This Hospital
+7.6%
State Avg
Latest Margin
-8.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $95M | -9.6% |
| FY2024 (proj) | $98M | -10.9% |
| FY2025 (proj) | $101M | -12.1% |